Apimeds Pharmaceuticals US, Inc.
APUS • AMEX
Apimeds Pharmaceuticals US, Inc. is a pharmaceutical preparations company trading on AMEX, led by CEO Youngjik Cho, with a market cap of $2.4M.
CEOYoungjik Cho
Next Earnings
Upcoming earnings announcement for Apimeds Pharmaceuticals US, Inc.
Date
Friday, May 22, 2026 (in 2 months)
Timing
Time TBD (10:19 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 3 earnings reports for Apimeds Pharmaceuticals US, Inc.
10-Q